Best Stocks Under $20 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $20.00 (20 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Galp Energia SGPS OTCMKTS:GLPEY$9.67 +0.28 (+2.99%) As of 03:51 PM EasternGalp Energia, SGPS, SA operates as an integrated energy operator in Portugal and internationally. The company operates through four segments: Upstream, Industrial & Midstream, Commercial, and Renewables and New Business. More about Galp Energia SGPSMarket Capitalization$13.45 billionP/E Ratio13.62Consensus RatingStrong BuyVolume26,713 sharesAverage Volume85,368 sharesToday's Range$9.52▼$9.68 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Birchcliff Energy OTCMKTS:BIREF$4.60 -0.01 (-0.12%) As of 03:51 PM EasternBirchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff EnergyMarket Capitalization$1.26 billionP/E Ratio13.16Consensus RatingStrong BuyVolume9,206 sharesAverage Volume84,214 sharesToday's Range$4.59▼$4.623. Ivanhoe Mines OTCMKTS:IVPAF$8.24 +0.12 (+1.50%) As of 03:58 PM EasternIvanhoe Mines Ltd. engages in the mining, development, and exploration of minerals and precious metals primarily in Africa. More about Ivanhoe MinesMarket Capitalization$11.16 billionP/E Ratio16.66Consensus RatingStrong BuyVolume109,279 sharesAverage Volume333,641 sharesToday's Range$8.20▼$8.364. Artelo Biosciences NASDAQ:ARTL$9.72 -0.31 (-3.09%) Closing price 04:00 PM EasternExtended Trading$9.68 -0.04 (-0.36%) As of 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Artelo Biosciences, Inc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. More about Artelo BiosciencesMarket Capitalization$6.80 millionP/E Ratio-0.54Consensus RatingStrong BuyConsensus Price Target$24.00 (+146.9% Upside)Volume25,538 sharesAverage Volume302,512 shares5. Glencore OTCMKTS:GLNCY$7.93 +0.09 (+1.15%) As of 04:00 PM EasternGlencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. More about GlencoreMarket Capitalization$47.24 billionConsensus RatingStrong BuyVolume568,281 sharesAverage Volume1.03 million sharesToday's Range$7.80▼$7.9450-Day Range$7.43▼$8.846. Adyen OTCMKTS:ADYEY$17.09 -0.23 (-1.33%) As of 03:59 PM EasternAdyen N.V. operates a payments platform in Europe, the Middle East, Africa, North America, the Asia Pacific, Latin America. More about AdyenMarket Capitalization$53.85 billionConsensus RatingBuyVolume452,599 sharesAverage Volume641,890 sharesToday's Range$16.84▼$17.0950-Day Range$16.75▼$19.887. Crescent Biopharma NASDAQ:CBIO$12.98 +0.08 (+0.62%) As of 04:00 PM EasternCrescent Biopharma, Inc operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. More about Crescent BiopharmaMarket Capitalization$253.76 millionP/E Ratio-0.37Consensus RatingBuyConsensus Price Target$25.50 (+96.5% Upside)Volume95,272 sharesAverage Volume40,785 shares8. atai Life Sciences NASDAQ:ATAI$4.13 +0.17 (+4.29%) Closing price 04:00 PM EasternExtended Trading$4.13 0.00 (0.00%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life SciencesMarket Capitalization$827.40 millionP/E Ratio-4.54Consensus RatingBuyConsensus Price Target$11.25 (+172.4% Upside)Volume5.32 million sharesAverage Volume3.63 million shares9. TuHURA Biosciences NASDAQ:HURA$3.25 +0.20 (+6.56%) Closing price 04:00 PM EasternExtended Trading$3.18 -0.07 (-2.03%) As of 05:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA BiosciencesMarket Capitalization$141.96 millionConsensus RatingBuyConsensus Price Target$12.67 (+289.7% Upside)Volume3.83 million sharesAverage Volume297,801 sharesToday's Range$3.11▼$3.9010. Serve Robotics NASDAQ:SERV$10.42 +0.04 (+0.39%) Closing price 04:00 PM EasternExtended Trading$10.30 -0.12 (-1.19%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Serve Robotics Inc designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. More about Serve RoboticsMarket Capitalization$594.01 millionP/E Ratio-9.06Consensus RatingBuyConsensus Price Target$18.67 (+79.1% Upside)Volume5.34 million sharesAverage Volume7.18 million shares11. zSpace NASDAQ:ZSPC$2.64 +0.35 (+15.28%) As of 04:00 PM EasternzSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpaceMarket Capitalization$61.51 millionConsensus RatingBuyConsensus Price Target$15.00 (+468.2% Upside)Volume228,821 sharesAverage Volume70,661 sharesToday's Range$2.37▼$2.9912. Select Water Solutions NYSE:WTTR$8.24 0.00 (-0.01%) Closing price 03:59 PM EasternExtended Trading$8.38 +0.14 (+1.65%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Select Water Solutions, Inc, together with its subsidiaries, provides water management and chemical solutions to the energy industry in the United States. More about Select Water SolutionsMarket Capitalization$990.41 millionP/E Ratio26.58Consensus RatingBuyConsensus Price Target$14.88 (+80.5% Upside)Volume1.32 million sharesAverage Volume1.25 million shares13. Telecom Italia OTCMKTS:TIIAY$5.18 +0.07 (+1.27%) As of 03:50 PM EasternTelecom Italia S.p.A., together with its subsidiaries, engages in the provision of fixed and mobile telecommunications services in Italy and internationally. More about Telecom ItaliaConsensus RatingBuyVolume2,307 sharesAverage Volume11,397 sharesToday's Range$5.18▼$5.2050-Day Range$4.23▼$5.1252-Week Range$2.19▼$5.2014. OS Therapies NYSE:OSTX$1.78 +0.11 (+6.59%) Closing price 04:00 PM EasternExtended Trading$1.74 -0.04 (-2.53%) As of 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS TherapiesMarket Capitalization$50.01 millionP/E Ratio-2.07Consensus RatingBuyConsensus Price Target$18.00 (+911.2% Upside)Volume309,323 sharesAverage Volume732,022 shares15. Ultrapar Participacoes NYSE:UGP$3.20 +0.19 (+6.15%) Closing price 03:59 PM EasternExtended Trading$3.26 +0.06 (+2.03%) As of 05:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar ParticipacoesMarket Capitalization$3.56 billionP/E Ratio8.88Consensus RatingBuyConsensus Price Target$3.20 (+0.2% Upside)Volume2.23 million sharesAverage Volume1.88 million shares16. VNET Group NASDAQ:VNET$7.80 -0.22 (-2.74%) Closing price 04:00 PM EasternExtended Trading$7.81 +0.01 (+0.13%) As of 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.VNET Group, Inc, an investment holding company, provides hosting and related services in China. It offers managed hosting services consisting of managed retail services, such as colocation services that dedicate data center space to house customers' servers and networking equipment, as well as allow customers to lease partial or entire cabinets for their servers; interconnectivity services that allow customers to connect their servers; value-added services, including hybrid IT, bare metal, firewall, server load balancing, data backup and recovery, data center management, server management, and backup server services; cloud services that allow customers to run applications over the internet using IT infrastructure; and VPN Services that extend customers' private networks by setting up connections through the public internet. More about VNET GroupMarket Capitalization$2.10 billionP/E Ratio-780.00Consensus RatingBuyConsensus Price Target$9.30 (+19.2% Upside)Volume5.97 million sharesAverage Volume7.98 million shares17. OnKure Therapeutics NASDAQ:OKUR$2.00 -0.03 (-1.48%) Closing price 04:00 PM EasternExtended Trading$2.19 +0.19 (+9.55%) As of 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure TherapeuticsMarket Capitalization$27.02 millionP/E Ratio-0.38Consensus RatingBuyConsensus Price Target$32.33 (+1,516.7% Upside)Volume56,289 sharesAverage Volume106,518 shares18. Coeur Mining NYSE:CDE$11.84 +0.23 (+1.98%) Closing price 03:59 PM EasternExtended Trading$11.86 +0.02 (+0.13%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Coeur Mining, Inc explores for precious metals in the United States, Canada, and Mexico. The company primarily explores for gold, silver, zinc, and lead properties. More about Coeur MiningMarket Capitalization$7.61 billionP/E Ratio32.00Consensus RatingBuyConsensus Price Target$9.79 (-17.4% Downside)Volume12.51 million sharesAverage Volume16.66 million shares19. Western Copper & Gold NYSE:WRN$1.28 -0.01 (-0.78%) As of 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$256.71 millionP/E Ratio-64.00Consensus RatingBuyConsensus Price Target$4.00 (+212.5% Upside)Volume306,225 sharesAverage Volume361,881 shares20. Franklin BSP Realty Trust NYSE:FBRT$10.97 +0.19 (+1.80%) Closing price 03:59 PM EasternExtended Trading$10.65 -0.32 (-2.95%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Benefit Street Partners operates as a self-managed real estate investment trust (REIT). BSP earns income from investing in a leveraged portfolio of residential mortgage pass-through securities consisting almost exclusively of adjustable-rate mortgage (ARM) securities issued and guaranteed by government-sponsored enterprises, either Federal National Mortgage Association (Fannie Mae) or Federal Home Loan Mortgage Corporation (Freddie Mac) (together, the government-sponsored enterprises (GSEs)), or by an agency of the federal government, Government National Mortgage Association (Ginnie Mae). More about Franklin BSP Realty TrustMarket Capitalization$902.94 millionP/E Ratio11.20Consensus RatingBuyConsensus Price Target$14.88 (+35.5% Upside)Volume426,277 sharesAverage Volume528,202 shares21. Sky Harbour Group NYSEAMERICAN:SKYH$10.95 0.00 (0.00%) Closing price 04:10 PM EasternExtended Trading$11.10 +0.15 (+1.32%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sky Harbour Group Corporation operates as an aviation infrastructure development company in the United States. It develops, leases, and manages general aviation hangars for business aircraft. More about Sky Harbour GroupMarket Capitalization$827.93 millionP/E Ratio-5.29Consensus RatingBuyConsensus Price Target$17.38 (+58.7% Upside)Volume228,991 sharesAverage Volume136,372 shares22. Quince Therapeutics NASDAQ:QNCX$1.83 +0.23 (+14.38%) Closing price 04:00 PM EasternExtended Trading$1.87 +0.04 (+2.19%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$98.13 millionP/E Ratio-1.32Consensus RatingBuyConsensus Price Target$8.14 (+345.0% Upside)Volume757,011 sharesAverage Volume239,953 shares23. Trevi Therapeutics NASDAQ:TRVI$7.33 +0.01 (+0.14%) Closing price 04:00 PM EasternExtended Trading$7.26 -0.08 (-1.02%) As of 05:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Trevi Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC) conditions targeting the central and peripheral nervous systems. More about Trevi TherapeuticsMarket Capitalization$859.74 millionP/E Ratio-17.45Consensus RatingBuyConsensus Price Target$20.38 (+178.0% Upside)Volume1.83 million sharesAverage Volume1.84 million shares24. Astria Therapeutics NASDAQ:ATXS$6.65 -0.03 (-0.45%) Closing price 04:00 PM EasternExtended Trading$6.66 +0.01 (+0.15%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Astria Therapeutics, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. More about Astria TherapeuticsMarket Capitalization$375.26 millionP/E Ratio-3.56Consensus RatingBuyConsensus Price Target$29.00 (+336.1% Upside)Volume239,653 sharesAverage Volume360,641 shares25. Maze Therapeutics NASDAQ:MAZE$13.74 +0.27 (+2.00%) As of 04:00 PM EasternWe are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. More about Maze TherapeuticsMarket Capitalization$601.81 millionConsensus RatingBuyConsensus Price Target$25.60 (+86.3% Upside)Volume99,692 sharesAverage Volume201,002 sharesToday's Range$13.22▼$13.85 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AST SpaceMobile on Track for Explosive Upside Oklo’s Stock Is Set up for a Correction—Buy It When It Bounces Alphabet Reclaims $200 Threshold—Bull Run Reignited? Apple & Trump: $100B Investment, Tariffs News Push Shares Up 13% How Vertiv Is Cashing in on AI's Power Crisis CrowdStrike Faces Valuation Test Before Key Earnings Report AMD Paves Path for Market Share Gains: Stock Rally Has Just Begun Post-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.